de Morgan Stanley Invesco Pharmaceuticals ETF PJP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 12.1 M | Vender |
102,176
-166,321
| -62% | -USD 18 M | ﹤0.01% | 3542 |
|
|
2026
Q1 | USD 27.9 M | Comprar |
268,497
+231,141
| +619% | +USD 24.4 M | ﹤0.01% | 2642 |
|
|
2025
Q4 | USD 3.91 M | Comprar |
37,356
+87
| +0.2% | +USD 8.75 k | ﹤0.01% | 4368 |
|
|
2025
Q3 | USD 3.45 M | Vender |
37,269
-1,998
| -5% | -USD 175 k | ﹤0.01% | 4428 |
|
|
2025
Q2 | USD 3.14 M | Vender |
39,267
-6,790
| -15% | -USD 542 k | ﹤0.01% | 4415 |
|
|
2025
Q1 | USD 3.99 M | Vender |
46,057
-60,931
| -57% | -USD 5.19 M | ﹤0.01% | 4116 |
|
|
2024
Q4 | USD 8.84 M | Comprar |
106,988
+52,377
| +96% | +USD 4.51 M | ﹤0.01% | 3513 |
|
|
2024
Q3 | USD 4.75 M | Vender |
54,611
-12,084
| -18% | -USD 1.03 M | ﹤0.01% | 3992 |
|
|
2024
Q2 | USD 5.48 M | Vender |
66,695
-8,431
| -11% | -USD 670 k | ﹤0.01% | 3802 |
|
|
2024
Q1 | USD 6.02 M | Comprar |
75,126
+29,366
| +64% | +USD 2.27 M | ﹤0.01% | 3771 |
|
|
2023
Q4 | USD 3.48 M | Vender |
45,760
-608
| -1% | -USD 43.5 k | ﹤0.01% | 4168 |
|
|
2023
Q3 | USD 3.36 M | Vender |
46,368
-46,984
| -50% | -USD 3.6 M | ﹤0.01% | 4022 |
|
|
2023
Q2 | USD 7.06 M | Vender |
93,352
-87,502
| -48% | -USD 6.68 M | ﹤0.01% | 3489 |
|
|
2023
Q1 | USD 13.7 M | Comprar |
180,854
+22,023
| +14% | +USD 1.7 M | ﹤0.01% | 2840 |
|
|
2022
Q4 | USD 12.5 M | Comprar |
158,831
+18,173
| +13% | +USD 1.4 M | ﹤0.01% | 2849 |
|
|
2022
Q3 | USD 10 M | Comprar |
140,658
+11,173
| +9% | +USD 833 k | ﹤0.01% | 2984 |
|
|
2022
Q2 | USD 9.7 M | Comprar |
129,485
+84,324
| +187% | +USD 6.39 M | ﹤0.01% | 3097 |
|
|
2022
Q1 | USD 3.59 M | Vender |
45,161
-2,655
| -6% | -USD 206 k | ﹤0.01% | 4033 |
|
|
2021
Q4 | USD 3.88 M | Vender |
47,816
-1,172
| -2% | -USD 92.6 k | ﹤0.01% | 3979 |
|
|
2021
Q3 | USD 3.79 M | Comprar |
48,988
+10,573
| +28% | +USD 853 k | ﹤0.01% | 4005 |
|
|
2021
Q2 | USD 3.09 M | Vender |
38,415
-2,532
| -6% | -USD 201 k | ﹤0.01% | 4258 |
|
|
2021
Q1 | USD 3.23 M | Comprar |
40,947
+8,692
| +27% | +USD 678 k | ﹤0.01% | 3856 |
|
|
2020
Q4 | USD 2.3 M | Vender |
32,255
-19,902
| -38% | -USD 1.33 M | ﹤0.01% | 4030 |
|
|
2020
Q3 | USD 3.33 M | Vender |
52,157
-95
| -0.2% | -USD 6.21 k | ﹤0.01% | 3135 |
|
|
2020
Q2 | USD 3.38 M | Comprar |
52,252
+2,646
| +5% | +USD 164 k | ﹤0.01% | 3069 |
|
|
2020
Q1 | USD 2.73 M | Comprar |
49,606
+1,933
| +4% | +USD 118 k | ﹤0.01% | 3070 |
|
|
2019
Q4 | USD 3.08 M | Vender |
47,673
-4,317
| -8% | -USD 263 k | ﹤0.01% | 3679 |
|
|
2019
Q3 | USD 2.95 M | Vender |
51,990
-10,769
| -17% | -USD 619 k | ﹤0.01% | 3439 |
|
|
2019
Q2 | USD 3.78 M | Vender |
62,759
-13,498
| -18% | -USD 828 k | ﹤0.01% | 3216 |
|
|
2019
Q1 | USD 4.97 M | Vender |
76,257
-90,269
| -54% | -USD 5.93 M | ﹤0.01% | 2724 |
|
|
2018
Q4 | USD 10.4 M | Comprar |
166,526
+63,078
| +61% | +USD 4.26 M | ﹤0.01% | 2084 |
|
|
2018
Q3 | USD 7.6 M | Comprar |
103,448
+26,142
| +34% | +USD 1.88 M | ﹤0.01% | 2708 |
|
|
2018
Q2 | USD 5.2 M | Vender |
77,306
-24,854
| -24% | -USD 1.6 M | ﹤0.01% | 3097 |
|
|
2018
Q1 | USD 6.38 M | Vender |
102,160
-27,092
| -21% | -USD 1.78 M | ﹤0.01% | 2768 |
|
|
2017
Q4 | USD 8.29 M | Vender |
129,252
-281
| -0.2% | -USD 18 k | ﹤0.01% | 2594 |
|
|
2017
Q3 | USD 8.46 M | Vender |
129,533
-6,182
| -5% | -USD 390 k | ﹤0.01% | 2449 |
|
|
2017
Q2 | USD 8.52 M | Vender |
135,715
-19,772
| -13% | -USD 1.19 M | ﹤0.01% | 2328 |
|
|
2017
Q1 | USD 9.14 M | Vender |
155,487
-21,916
| -12% | -USD 1.28 M | ﹤0.01% | 2289 |
|
|
2016
Q4 | USD 9.9 M | Comprar |
177,403
+25,405
| +17% | +USD 1.46 M | ﹤0.01% | 2260 |
|
|
2016
Q3 | USD 9.37 M | Vender |
151,998
-2,739
| -2% | -USD 179 k | ﹤0.01% | 2063 |
|
|
2016
Q2 | USD 9.8 M | Vender |
154,737
-12,806
| -8% | -USD 805 k | ﹤0.01% | 1995 |
|
|
2016
Q1 | USD 10.1 M | Vender |
167,543
-351,302
| -68% | -USD 21.5 M | ﹤0.01% | 1861 |
|
|
2015
Q4 | USD 36.3 M | Vender |
518,845
-36,404
| -7% | -USD 2.58 M | 0.01% | 988 |
|
|
2015
Q3 | USD 36.8 M | Vender |
555,249
-17,334
| -3% | -USD 1.35 M | 0.01% | 972 |
|
|
2015
Q2 | USD 44.9 M | Vender |
572,583
-9,116
| -2% | -USD 710 k | 0.02% | 932 |
|
|
2015
Q1 | USD 44.4 M | Comprar |
581,699
+1,392
| +0.2% | +USD 102 k | 0.02% | 917 |
|
|
2014
Q4 | USD 38.6 M | Vender |
580,307
-95,759
| -14% | -USD 6.38 M | 0.01% | 1006 |
|
|
2014
Q3 | USD 43 M | Vender |
676,066
-27,532
| -4% | -USD 1.7 M | 0.02% | 900 |
|
|
2014
Q2 | USD 43 M | Vender |
703,598
-77,842
| -10% | -USD 4.51 M | 0.02% | 885 |
|
|
2014
Q1 | USD 44.3 M | Comprar |
781,440
+71,188
| +10% | +USD 4.04 M | 0.02% | 812 |
|
|
2013
Q4 | USD 38 M | Comprar |
710,252
+59,273
| +9% | +USD 2.97 M | 0.02% | 896 |
|
|
2013
Q3 | USD 30 M | Comprar |
650,979
+168,375
| +35% | +USD 7.68 M | 0.01% | 951 |
|
|
2013
Q2 | USD 20.4 M | Comprar |
+482,604
| Nuevas | +USD 20.1 M | 0.01% | 1166 |
|
Otros fondos que tienen PJP en su cartera
Posición de Morgan Stanley en PJP: resumen de T2 2026
Morgan Stanley redujo su participación en Invesco Pharmaceuticals ETF (PJP) en 62% durante T2 2026, al vender acciones por un valor estimado de USD 18 M, y conservó 102,176 acciones valuadas en USD 12.1 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3542.
Morgan Stanley reportó por primera vez una posición en PJP en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 44.9 M en T2 2015. Al cierre de T2 2026, 116 fondos que sigue Wall St. Rank mantienen una posición en PJP.
- Al cierre de T2 2026, Morgan Stanley tenía 102,176 acciones de Invesco Pharmaceuticals ETF con un valor de USD 12.1 M.
- Morgan Stanley vendió 166,321 acciones de Invesco Pharmaceuticals ETF en T2 2026, por un valor estimado de USD 18 M.
- Invesco Pharmaceuticals ETF representó ﹤0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 3542.
- Morgan Stanley reportó por primera vez una posición en Invesco Pharmaceuticals ETF en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Morgan Stanley en Invesco Pharmaceuticals ETF alcanzó su máximo de USD 44.9 M en T2 2015.
- Al cierre de T2 2026, 116 fondos que sigue Wall St. Rank tenían Invesco Pharmaceuticals ETF en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.